Rhythm Pharmaceuticals Inc
SWB:1RV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhythm Pharmaceuticals Inc
SWB:1RV
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
SWB:ERCB
|
SE |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
OTC:FILAF
|
IT |
|
Koninklijke Philips NV
AEX:PHIA
|
NL |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
F:3S0
|
IT |
|
M
|
MillerKnoll Inc
XBER:MHR
|
US |
|
W
|
Westlake Corp
F:UEO
|
US |
|
China Resources Land Ltd
F:CHZ0
|
HK |
|
Bid Corporation Ltd
OTC:BDDDY
|
ZA |
|
H
|
Hershey Co
F:HSY
|
US |
|
Ageas SA
OTC:AGESF
|
BE |
|
Helvetia Holding AG
LSE:0ACB
|
CH |
|
Volkswagen AG
F:VOW3
|
DE |
|
P
|
Petroleo Brasileiro SA Petrobras
DUS:PJXA
|
BR |
|
B
|
Bank Negara Indonesia (Persero) Tbk PT
SWB:BKE1
|
ID |
|
N
|
Nestle SA
XBER:NESR
|
CH |
|
V
|
Vulcan Materials Co
XBER:VMC
|
US |
Wall St Price Targets
1RV Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 1RV is 122.17 EUR with a low forecast of 91.07 EUR and a high forecast of 143.37 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1RV's stock price target?
Price Target
122.17
EUR
According to Wall Street analysts, the average 1-year price target for 1RV is 122.17 EUR with a low forecast of 91.07 EUR and a high forecast of 143.37 EUR.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.
What is the Gross Profit forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
51%
The compound annual growth rate for Gross Profit over the next 6 years is 51%.
